Oncology
11 drugs are in development for Solid Tumor.
- Companies
- 6
- Clinical trials
- 97
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Solid Tumor pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(5)
| Drug | Company |
|---|---|
| CRB-601 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) |
| Selpercatinib | ELI LILLY & Co (LLY) |
| tpst-2003 | Tempest Therapeutics, Inc. (TPST) |
| tpst-2206 | Tempest Therapeutics, Inc. (TPST) |
| tpst-3206 | Tempest Therapeutics, Inc. (TPST) |
Phase 2(1)
| Drug | Company |
|---|---|
| TYRA-300 | Tyra Biosciences, Inc. (TYRA) |
Phase 1(1)
| Drug | Company |
|---|---|
| tpst-1495 | Tempest Therapeutics, Inc. (TPST) |
Preclinical(1)
| Drug | Company |
|---|---|
| tpst-3003 | Tempest Therapeutics, Inc. (TPST) |
Phase 1/Phase 2(3)
About this indication
Solid Tumor context
Oncology·MeSH: Neoplasms (D009369)
Narrower concept of MeSH descriptor Neoplasms
Compare drugs
Frequently asked questions
How many drugs are in development for Solid Tumor?
BioSniper tracks 11 drugs in development for Solid Tumor across 6 companies.
How many clinical trials target Solid Tumor?
There are 97 clinical trials targeting Solid Tumor tracked by BioSniper.